Skip to main content
SpringerLink
Log in

Recurrence rates and survival in patients with colorectal cancer do not appear to be improved by adding levamisole to adjuvant chemotherapy or by increasing the dosage of calcium levofolinate

  • Clinical study
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Recurrence rates and survival in patients with colorectal cancer do not appear to be improved by adding levamisole to adjuvant chemotherapy or by increasing the dosage of calcium levofolinate. Inpharma Wkly. 1237, 15 (2000). https://doi.org/10.2165/00128413-200012370-00032

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-200012370-00032

Keywords

Search

Navigation